Effect of the PARP inhibitor veliparib on germ cell tumor cell lines-Reference-Cited by-同舟云学术

Effect of the PARP inhibitor veliparib on germ cell tumor cell lines

Published:2022-09-21 Issue:5 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Schmidtova Silvia¹,Udvorkova Natalia¹,Cierna Zuzana²,Horak Samuel²,Kalavska Katarina¹,Chovanec Michal³,Rojikova Lucia¹,Vulevova Miriam⁴,Kucerova Lucia¹,Mego Michal³

Affiliation:

1. Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, 845 05 Bratislava, Slovakia

2. Department of Pathology, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia

3. Translational Research Unit, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia

4. Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference86 articles.

1. Human germ cell tumours from a developmental perspective;Oosterhuis;Nat Rev Cancer,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Estimates of over-time trends in incidence and mortality of testicular cancer from 1990 to 2030;Cai;Transl Androl Urol,2020

4. Current pharmacotherapy for testicular germ cell cancer;Alsdorf;Expert Opin Pharmacother,2019

5. Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design;Feldman;Cancer,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients;International Journal of Molecular Sciences;2023-04-26